Monograph: Erythromycins General Statement

Erythromycins General Statement

Die Inhalte stehen nur registrierten Benutzern zur Verfügung.

Sie sind zum ersten mal hier und möchten die Datenbank 10-Tage kostenlos testen, dann registrieren Sie sich einmalig. Nach der Registrierung melden Sie sich mit Ihrem Benutzernamen und Passwort an.

Sie sind bereits bei DrugBase registriert und möchten diese Datenbank 10-Tage kostenlos und unverbindlich testen? Dann melden Sie sich mit Ihren Zugangsdaten an und wählen Sie anschließend die Datenbank, die Sie testen möchten.

Full Title

Erythromycins General Statement

Classification

Introduction

Introduction

...

...

...

Uses

Uses

...

Streptococcal Infections

...

Pharyngitis and Tonsillitis

...

Prophylaxis of Recurrent Rheumatic Fever

...

Prevention of Perinatal Group B Streptococcal Disease

...

Prevention of Bacterial Endocarditis

...

Acute Otitis Media

...

Respiratory Tract Infections

...

Community-acquired Pneumonia

...

Outpatient Regimens for CAP

...

Inpatient Regimens for CAP

...

Skin and Skin Structure Infections

...

Acne

...

Amebiasis

...

Anthrax

...

Bartonella Infections

...

Campylobacter Infections

...

Chancroid

...

Patient Follow-up and Management of Sexual Partners

...

Chlamydial Infections

...

Urogenital Chlamydial Infections in Adults and Adolescents

...

Patient Follow-up and Management of Sexual Partners

...

Chlamydial Infections during Pregnancy

...

Chlamydial Infections in Neonates and Infants

...

Chlamydial Ophthalmia Neonatorum

...

Chlamydial Pneumonia in Infants

...

Urogenital Chlamydial Infections in Children

...

Lymphogranuloma Venereum

...

Chlamydia psittaci Infections

...

Diphtheria

...

Gonorrhea and Associated Infections

...

Granuloma Inguinale (Donovanosis)

...

Legionnaires’ Disease

...

Mycobacterium avium Complex (MAC) Infections

...

Nongonococcal Urethritis

...

Pertussis

...

Spirochetal Infections

...

Lyme Disease

...

Syphilis

...

Preoperative Intestinal Antisepsis

...

Other Uses

...

...

Dosage and Administration

Dosage and Administration

...

Administration

...

Dosage

...

Dosage in Renal Impairment

...

...

Cautions

Cautions

...

GI Effects

...

Hepatic Effects

...

Local Effects

...

Cardiac Effects

...

Other Adverse Effects

...

Precautions and Contraindications

...

Mutagenicity and Carcinogenicity

...

Pregnancy, Fertility, and Lactation

...

Pregnancy

...

Fertility

...

Lactation

...

...

Drug Interactions

Drug Interactions

...

Drugs Affecting or Metabolized by Hepatic Microsomal Enzymes

...

Anti-infective Agents

...

Antifungal Agents

...

Astemizole and Terfenadine

...

Carbamazepine

...

Cardiac Drugs

...

Calcium-channel Blocking Agents

...

Cisapride

...

Clozapine

...

Cyclosporine

...

Ergot Alkaloids

...

Midazolam and Triazolam

...

Theophylline

...

Warfarin

...

...

Pharmacokinetics

Pharmacokinetics

...

Absorption

...

Distribution

...

Elimination

...

...

Chemistry and Stability

Chemistry and Stability

...

Chemistry

...

Stability

...

...

Spectrum Section

Spectrum

...

In Vitro Susceptibility Testing

...

Disk Susceptibility Tests

...

Dilution Susceptibility Tests

...

...

Resistance Section

Resistance

...

...

Mechanism of Action

Mechanism of Action

...

...

Laboratory Test Interference

Laboratory Test Interferences

...

...

Common monograph Elements

Related Monographs

...

...

References

References

...

...

Copyright

AHFS® Drug Information. © Copyright, 1959-2021, Selected Revisions April 9, 2018. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.

† Use is not currently included in the labeling approved by the US Food and Drug Administration.

Quelle

AHFS Drug Information